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Abstract
Summary We have characterised 997 hip fracture patients from a representative 45 Spanish hospitals, and followed them up
prospectively for up to 4months. Despite suboptimal surgical delays (average 59.1 hours), in-hospital mortality was lower than in
Northern European cohorts. The secondary fracture prevention gap is unacceptably high at 85%.
Purpose To characterise inpatient care, complications, and 4-month mortality following a hip or proximal femur fracture in Spain.
Methods Design: prospective cohort study. Consecutive sample of patients ≥ 50 years old admitted in a representative 45
hospitals for a hip or proximal femur fragility fracture, from June 2014 to June 2016 and followed up for 4 months post-fracture.
Patient characteristics, site of fracture, in-patient care (including secondary fracture prevention) and complications, and 4-month
mortality are described.
Results A total of 997 subjects (765 women) of mean (standard deviation) age 83.6 (8.4) years were included. Previous history of
fracture/s (36.9%) and falls (43%) were common, and 10-year FRAX-estimated major and hip fracture risks were 15.2% (9.0%)
and 8.5% (7.6%) respectively. Inter-trochanteric (44.6%) and displaced intra-capsular (28.0%) were the most common fracture
sites, and fixation with short intramedullary nail (38.6%) with spinal anaesthesia (75.5%) the most common procedures. Surgery
and rehabilitation were initiated within a mean 59.1 (56.7) and 61.9 (55.1) hours respectively, and average length of stay was 11.5
(9.3) days. Antithrombotic and antibiotic prophylaxis were given to 99.8% and 98.2% respectively, whilst only 12.4% received
secondary fracture prevention at discharge. Common complications included delirium (36.1 %) and kidney failure (14.1%), with
in-hospital and 4-month mortality of 2.1% and 11% respectively.
Conclusions Despite suboptimal surgical delay, post-hip fracture mortality is low in Spanish hospitals. The secondary fracture
prevention gap is unacceptably high at > 85%, in spite of virtually universal anti-thrombotic and antibiotic prophylaxis.
Keywords Hip fracture . Registries . Osteoporosis and patient caremanagement
Introduction
Due to an increase in life expectancy [1], the burden of hip
fractures is expected to reach 319 million fractures worldwide
by 2040 [2], which poses a social and economic challenge for
health care providers. Hip fractures are associated with an
increased mortality and disability; mortality increases up to
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33% at the end of the first year [3] and disability has been
estimated at 5964 DALYs per 1,000 individuals [4]. In
Europe, osteoporotic fractures account for a higher loss of
years due to disability than most cancers [5]. Moreover, the
stress of having a hip fracture affects not only the patient (due
to the pain, the need of surgery and the usual long in-hospital
stays) but also their family members and caregivers [6].
In this context, improving hip fracture care is becoming
increasingly important for health care providers. Fracture pa-
tients are often frail and present many previous comorbid con-
ditions [7]; hence, their management frequently requires
long hospital stays and a complex process [8, 9]. For this
reason, many hospitals have shifted towards a multi-
disciplinary team to take care of these patients, which
includes several specialities such as orthopaedists, general
medicine, anaesthesiologists, rehabilitation, geriatricians,
social workers, and primary care practitioners [8].
Geographical variations of hip fracture, with Spain ac-
counting with one of the lowest hip fracture rates in Europe
[10], renders comparison difficult with other national hip frac-
ture registries reports previously published. Moreover, there is
a lack of prospective accurate information on the current hos-
pital care received by hip fracture patients, as well as on the
post-operative complications and overall survival in Spain
[11]. We therefore aimed to characterise patients, inpatient
care (including surgery, rehabilitation, and prophylaxis of
complications and/or secondary fracture prevention), in-
patient complications risk, and up to 4-month mortality
in a prospective cohort of Spanish hip or proximal femur
fracture patients.
Methods
Study design and setting
We conducted a multi-centric, prospective cohort study in a
representative 45 hospitals from 15 autonomic regions from
Spain.
Participants
Inclusion criteria of contributing hospitals
Hospitals were eligible to participate in the study if they had
an ortho-geriatric specialist or a medical doctor responsible for
the coordination of inpatient care for hip fracture patients dur-
ing their index hospital admission. The hospitals were selected
considering not only their geographic representativeness but
also the type/volume/size of hospital to maximise the repre-
sentativeness of the study sample.
Inclusion/exclusion criteria of cases
All adults of at least 50 years old, presenting with a fra-
gility fracture of the hip or proximal femur at any of the
participating hospitals during the recruitment period
(June 2014 to June 2016) were invited up to a maximum
of 30 consecutive patients per hospital. Participants (or
their carers if they were unable to do so) signed consent
and were included at the moment of hospital admission.
From then on, they received usual care according to local
protocols/practice.
A fragility fracture was defined as that produced by a low
energy impact or without previous traumatism. Subjects with
fractures due to neoplastic disorders (including primary or
metastatic bone cancer) or in an irradiated site, traffic acci-
dents, produced by falls from a height higher than 1.80 m,
peri-prosthetic or distal femur fractures, and those with a pre-
vious ipsilateral femur fracture were excluded. Additionally,
patients who for any medical or psychological reason were
unable to receive usual care, or those who were already par-
ticipating in related (with anti-osteoporosis drug/s or fracture
care/surgery as intervention/s under study) clinical trial/s were
also ineligible.
Follow-up
All subjects were followed up for up to 4 months after their
index admission date.
Study outcomes
The main measurements of this study were socio-
demographic features of the patient (age, sex, body mass in-
dex, civil status, ethnic and educational background, place of
residence previous to fracture), comorbid conditions such as
previous fractures, diagnose of osteopenia, osteoporosis, rheu-
matoid arthritis, and secondary osteoporosis (which was con-
firmed if the patient had any of the following disorders related
to osteoporosis: type 1 diabetes, adult osteogenesis
imperfecta, hyperthyroidism or premature menopause (<
45 years old), chronic malnutrition or malabsorption, or
chronic liver disease). Falls (number of falls in the last year),
date of menopause, medications (anti-osteoporosis medica-
tion), fracture risk factors (FRAX tool), characteristics of the
fracture episode (circumstances, site, and type of fracture), in-
patient care received (pre-operative assessment, type of anaes-
thesia, ASA (American Society of Anaesthesiologists) physi-
cal status classification system) grade, surgery, the post-
operative management (early mobilisation, constipation pre-
vention or need or urinary catheterisation) and rehabilitation,
prophylaxis of post-surgery complications, and secondary
fracture prevention measures, type of multi-disciplinary units
involved (group of health care professionals including
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physiotherapy, occupational therapy, nursery and medicine)
who are responsible of the assessment and treatment of hip
fracture patients) as well as baseline and post-fracture clinical
outcomes (inpatient complications and up to 4-month mortal-
ity) were also collected.
Statistical methods
A descriptive analysis was conducted for all measurements;
continuous variables were summarised as mean, median, stan-
dard deviation, and quartiles (inferior, superior, minimum,
maximum). The number and percentage of patients in each
group was reported for each categorical variable. Kaplan-
Meier curves were computed to depict post-fracture mortality
up to 4 months of follow-up and after stratification per age and
sex. All the analyses were stratified by sex, age, previous
fractures history, and type of fracture.
Results
Baseline characteristics of study participants
and contributing hospitals
A total of 997 subjects admitted to 45 hospitals were included
between June 2014 and June 2016, of whom 856 (85.9%)
completed 4 months of follow-up, 99 (9.9%) died in the same
period, and 42 (4. 2%) were lost to follow up. Baseline char-
acteristics of the study population are reported in Table 1. In
brief, participants were mostly widowed Caucasian old wom-
en, with primary education levels, who lived in the communi-
ty until they fractured. Key fracture risk factors were common,
including previous fractures (36.5%) and at least one fall in the
previous year (43%). Ten-year absolute fracture risk assessed
using the FRAX tool was estimated at a mean (standard devi-
ation) of 15.2% (9.0%) and 8.5% (7.6%) for major osteopo-
rotic and hip fracture respectively. Regarding the characteris-
tics of contributing hospitals, median (inter-quartile range)
volume was of 290 (200–370) hip fractures per annum, and
dedicated staff included a median (inter-quartile range) of 12
(7–15) clinicians.
Descriptive analysis
Fracture type and circumstances at the time of fracture are
reported in Table 1. Hip fractures were predominantly either
inter-trochanteric (44.6%) followed by intra-capsular
displaced (28%), whilst 7 (0.7%) were classified as atypical
femoral fractures. Most common circumstance/s leading to
fracture were tripping (56.1%) or slipping (23%).
In-patient care and management of the fracture
The in-patient pre-operative care and treatments as well as the
characteristics of the surgery carried out are detailed in
Table 2. Upon admission, 60.6% of the subjects were assessed
using a multi-disciplinary protocol, and a medical doctor
reviewed 61.9% of them previous to surgery. The three most
common surgical procedures carried out were (in order) (1)
internal fixation with a short intramedullary nail (38.6%),
followed by (2) bipolar-cemented hemi-arthroplasty (15%),
and (3_ internal fixation with long intramedullary nail
(14.9%). In 75.5% of these surgeries, spinal anaesthesia was
used, and almost all of the subjects received either antithrom-
botic or antibiotic prophylaxis (99.8% and 98.2%
respectively).
Different multi-disciplinary models were observed in
Spanish hospitals during the whole hospital stay of the patient.
An 89.5% of the participating hospitals reported formally co-
ordinated care with either internal medicine or geriatrics. A
multi-disciplinary protocol was used to guide care in 76.3% of
the cases, and the process was usually co-ordinated by specific
staff members (either specialised nurse/s or medical doctors).
Regarding surgical delays and time to rehabilitation, these
were on mean (standard deviation) of 59.1 (56.7) hours and
61.9 (55.1) hours respectively. Total length of stay was of
mean (standard deviation) 11.5 (9.3) days.
Post-operative care/management and complications after
the fracture are summarised in Table 2. The most common
inpatient complications were delirium (36.1%) and kidney
failure (14.1%). The total in-hospital mortality was 2.1%.
Secondary fracture prevention
At discharge, bone health was reportedly not assessed for
23.6%, assessed but treatment deemed unnecessary/
inappropriate for 20.5% of the participants. In addition,
14.9% were awaiting a bone health clinical assessment, and
3.2% were discharged pending a DXA scan before treatment.
Regarding anti-osteoporosis medication/s, a 21.4% of the par-
ticipants were prescribed anti-osteoporosis drug therapy at
discharge (8.3% continuing previous therapy and the other
12.1% newly started treatments during hospital admission),
and the percentage of such treatment increased but remained
suboptimal at 32.1% and 37.8% at 1 and 4 months
respectively.
Mortality in the first 4 months after discharge
Mortality in the first 4 months, overall, and stratified by sex is
reported in Tables 3 and 4 and in Figs. 1 and 2. Kaplan-Meier
survival estimates show an overall decreasing trend of mortal-
ity from the admission date to the end of the 4th month after
the fracture, reaching 11% at the end of the 4th month. Results
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Table 1 Baseline characteristics of the population and fractures
Baseline characteristics of the population included
Variable N (%)
Age at fracture, mean (SD) 83.59 (8.4)
BMI, mean (SD) 25.17 (4.3)
Sex (women) 765 (76.7)
Current smoker 48 (4.9)
Alcohol drinking > 3 units/day 35 (3.6)
Ethnic background (Caucasian) 993 (99.6)
Education (level achieved) None 199 (20.1)
Basic/primary 673 (67.9)
Secondary 89 (9.0)
University degree 30 (3.0)
Missing data 6





Previous residence before fracture Own home 817 (82.1)
Hospital 2 (0.2)
Care home 173 (17.4)
Unknown 3 (0.3)
Missing data 2
ASA grade Healthy person 55 (5.6)
Mild systemic disease 335 (33.8)
Severe systemic disease 486 (49.0)
Severe systemic disease that is a constant threat to life 115 (11.6)
Missing data 6
Previous fracture Hip 101 (10.2)
Spine (clinical) 72 (7.3)
Any fracture 364 (36.5)
Rheumatoid arthritis 20 (2.0)
Secondary osteoporosis 57 (5.8)
Parental hip fracture history 79 (8.1)
Steroid user 38 (3.9)




4 or more 100 (10.3)
FRAX Major osteoporotic fracture risk, mean (SD) 15.17 (8.95)
Hip fracture risk, mean (SD) 8.49 (7.63)
Baseline characteristics of the fractures
Fracture type Fragility 988 (99.1)
Atypical femoral fracture 7 (0.7)
Unknown 2 (0.2)
Circumstances at the time of fracture Tripping 556 (56.1)
Slipping 228 (23.0)
Whilst sitting down 93 (9.4)
Whilst lying in bed 28 (2.8)
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stratified by sex showed that men had an increased mortality
after discharge compared to women (Table 4). When stratify-
ing by age, we found that survival rates were similar in sub-
jects up to 85 years old after which it drops drastically
reaching 67% of survival rates among the oldest subjects (>
90 years old) at the end of this period (figure 3 in the
supplementary material).
Discussion
In this multi-centric, prospective, observational cohort study,
we found that most of the subjects with hip fracture analysed
were Caucasian elderly women with previous fracture/s, falls,
and an intermediate to high 10-year fracture risk. Most of the
fractures were inter-trochanteric and were produced by non-
traumatic accidents. The majority of the subjects were first
assessed through a multi-disciplinary protocol and followed
afterwards either by a specific fall prevention team or by a
multidisciplinary team.
Despite hospital delay in the surgery and rehabilitation,
total length of stay was not affected (11.5 days).
The most common surgical procedure carried out was an
internal fixation with short intra-medullary nail with spinal
anaesthesia and the most frequent complications were deliri-
um and kidney failure. Nearly all of the subjects were previ-
ously treated with either antithrombotic or antibiotic
prophylaxis.
At discharge, the majority of the subjects returned to their
own home and only one fifth of them were assessed for oste-
oporosis treatment. Hospital mortality remained low 2.1%,
and there was an overall decreasing trend in the following
4 months after the fracture.
Hip fractures result in a socio-economic burden for health
care systems and are expected to increase due to the ageing of
the population. Therefore, optimising the treatment and care
of these fractures is a top priority for health care providers [5].
Baseline characteristics of our population did not differ from
the ones analysed in other recent hip fracture registries or
audits [12–16]. As in our report, most of them were old wom-
en with an ASA score between 2 and 3; however, our results
show that a large proportion of our subjects were at an
increased risk of fracture at the time of admission; over 36%
reported having a previous fracture and at least one fall in the
last year.
The fracture risk assessment tool (FRAX) was also calcu-
lated and despite it has been validated in many countries in-
cluding Spain, an underestimation of the fracture risk among
Spanish women has been previously reported [17]. To over-
come this, new thresholds have been proposed [3]; low risk <
5; intermediate risk ≥ 5 to < 7.5 and high risk ≥ 7.5. If we take
these thresholds into account, our population would be con-
sidered a high-risk of fracture population; however, if we take
into account the original thresholds of the FRAX (low risk <
10; intermediate risk ≥ 10 to < 20; high risk ≥ 20) our subjects
would be in the intermediate risk for major osteoporotic frac-
tures and low risk for hip fractures.
When analysing the characteristics of the fracture admitted
to the hospital devices and the type of surgery carried out, the
majority were inter-trochanteric fractures due to slipping or
tripping, which differs from some of the studies published,
especially in the USA and the UK [13–15], where the most
frequent fractures were femoral neck fractures [14], non-
intertrochanteric extra-capsular fractures [15], and
intracapsular fractures [13]. Seven cases were classified
as atypical hip fractures. Environmental differences,
such as the weather or the pavement conditions, could
lead to different fracture mechanisms and, therefore, to
different type of fractures. The most common surgical
procedure carried out in the hospitals analysed was an
internal fixation with short intra-medullary nail, which
is in agreement with the type of surgery used for these
fractures in some of the other registries [14, 16].
Our study reported a delay in the time to surgery and in
the time to the initiation of the rehabilitation (59 and
nearly 62 h after the fracture admission respectively).
The Catalan Government carried out another report in
2013 and the mean delay from admission to surgery in
68% of the hospitals analysed did not exceed the 48 h
[7]. Possible explanations for this increase in the delay
might be related to healthcare delivery and organisational
factors. Median time to surgery was also reported in the
UK registry [13] and was found to be lower than ours
(24.5 h). Reasons for delay in our hospitals could be
Table 1 (continued)
Other 198 (20.0)
Fracture site Displaced, intra-capsular 279 (28.0)




BMI, Body Mass Index; ASA grade, American Society of Anaesthesiologists physical status classification status; Falls, falls in the previous year; FRAX,
fracture risk assessment tool
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Table 2 Inpatient pre-and post-operative care, characteristics of the surgery, and complications after the fracture
Pre-operative care/treatments
Variable N (%)
Multi-disciplinary assessment protocol upon admission 602 (60.6)
Medical/specialised nurse input Geriatric assessment 352 (35.3)
Assessed by a physician 617 (61.9)
Specialised nurse 359 (37.4)
Not assessed 109 (10.9)
Antibiotic prophylaxis (common regimen/s given) Cephalosporines 886
Other antibiotics 78
Anti-thrombotic prophylaxis Pharmacological 981
Mechanic/physical measures 164
Previous oral anticoagulants 124
Previous platelet inhibitor/s therapy 212
Surgery
Anaesthesia (type of) Only general 74 (7.5)
General and nerve block 9 (0.9)
General and spinal anaesthesia 15 (1.5)
General and epidural anaesthesia 36 (3.7)
Only spinal anaesthesia 743 (75.5)
Spinal anaesthesia and nerve block 70 (7.1)
others 37 (3.8)
Missing data 13
Surgery (type of procedure) Internal fixation-sliding hip screw 32 (3.2)
Internal fixation-cannulated screw 33 (3.3)
Internal fixation-long intramedullary nail 148 (14.9)
Internal fixation-short intramedullary nail 384 (38.6)
Unipolar hemiarthroplasty (non-cemented, non-coated) 35 (3.6)
Unipolar hemiarthroplasty (non-cemented-coated with hydroxyapatite) 12 (1.2)
Unipolar hemiarthroplasty (cemented) 76 (7.7)
Bipolar hemiarthroplasty (non-cemented-non-coated) 8 (0.8)
Bipolar hemiarthroplasty (non-cemented, coated with hydroxyapatite) 14 (1.4)
Bipolar hemiarthroplasty (cemented) 149 (15.0)
Arthroplasty-total hip replacement (non-cemented, non-coated) 11 (1.1)
Post-operative care/treatments
Review by internal medicine/geriatrics (grade) Consultant 666 (71.0)
Senior resident doctor 61 (6.5)
Junior resident doctor 13 (1.4)
Not reviewed/assessed 186 (19.8)
Head of department 12 (1.3)
Missing data 59
Seen by falls prevention team 424 (42.7)
Multi-disciplinary team review/care 537 (54.1)
Early mobilisation 873 (87.8)
Prevention of constipation 657 (66.1)
Post-operative rehabilitation 592 (59.4)
Destination at discharge Own home 490 (49.3)
Care home 250 (25.1)
Home hospitalisation 4 (0.4)
Rehabilitation centre 138 (13.9)
Long-term community hospital 78 (7.8)
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due to worse patient conditions previous to the surgery
(e.g. comorbidities) or because of a lower number of ma-
terial means and resources to carry on the surgeries (lower
number of operating rooms or surgeons). However, a
main limitation of the Patel et al. study [13] is that it is
based on only 1 hospital (compared to the 48 hospitals
were our study was carried out), limiting its external va-
lidity. Despite the delay in the surgery our in-hospital
mortality rates (2.1%) were found to be lower than that
reported in other countries [12–14]. International compar-
ison of mortality rates is difficult, given that not all of
them measured it at the same time.
Regarding the length of stay (LOS), there is a higher vari-
ability of results in the available literature [12–14, 16], leading
to think that it could be due to overall health care system
structure and fracture care practices in the various countries
and the different population analysed. A recent meta-analysis
and systematic review showed that multidisciplinary care
models improved the patient outcomes in terms of LOS, in-
patient and long-term mortality [8]. Our results are in accor-
dance with the actual trends of implementing a multidisciplin-
ary care; the majority of our hospitals carried out a multi-
disciplinary protocol assessed by a physician and during the
post-operative care, the assessment was carried out either by a
specific fall prevention team or by a multidisciplinary team,
depending on the hospital analysed.
Regarding the anti-osteoporosis medication, only 20.5% of
the subjects in our population were assessed for osteoporosis
treatment during their hospital stay and at discharge, only
12.4% received anti-osteoporosis medication, which
Table 2 (continued)
Others 17 (1.7)
Complications after the fracture
Delirium 360 (36.1)
Urinary tract infection 97 (9.7)
Respiratory tract infection 80 (8.0)
Kidney failure 140 (14.1)
Heart failure 82 (8.2)
Pressure ulcers 36 (3.63)
Surgical wound infection 8 (0. 8)
Prosthesis or material infection 6 (0.6)
In-hospital mortality 21 (2.1)
Table 3 Overall mortality up to
4 months of follow-up: life table Interval (months) N at end of interval Deaths Lost Survival 95% conf. interval
0 1 997 42 15 0.958 0.943 0.969
1 2 940 29 31 0.927 0.909 0.942
2 3 880 20 4 0.906 0.886 0.923
3 4 856 8 35 0.898 0.877 0.915
Table 4 Mortality up to 4 months
of follow-up stratified by sex: life
table
Interval (months) N at end of interval Deaths Lost Survival 95% conf. interval
Men
0 1 232 15 4 0.935 0.894 0.960
1 2 213 12 8 0.881 0.831 0.917
2 3 193 6 1 0.854 0.800 0.894
3 4 186 2 7 0.844 0.790 0.886
Women
0 1 765 27 11 0.965 0.949 0.976
1 2 727 17 23 0.942 0.922 0.956
2 3 687 14 3 0.922 0.901 0.939
3 4 670 6 28 0.914 0.891 0.932
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increased up to 37.8% in the first 4 months after discharge.
The low proportion of subjects with anti-osteoporosis medi-
cation has been previously reported [16]. In a report carried
out by the Catalan Government in 2013 that aimed to analyse
the healthcare procedures in this region [7] among subjects
aged at least 65 years old who were hospitalised because of
a femur fracture, patients who had a fracture consumed 10%
less anti-osteoporotic medications than those without a
fracture.
Despite that the anti-osteoporosis medication is recom-
mended by the main Spanish Traumatology Society guide-
lines [9] especially among subjects at high risk of fracture such
as those that have already sustained a hip fracture, less than
50% of our subjects were treated at the end of the 4th month
after the hip fracture. This percentage might be higher if we
add those that were already taking an osteoporosis treatment
before the hip fracture.
This is an observational report and therefore is subject
to the limitations of this type of study. However, other
limitations need to be considered; first, we were unable
to gather any information regarding the possible causes of
delay of the surgery/rehabilitation or determine if the LOS
was influenced by the pre-fracture comorbidities of the
subjects. Second, by excluding subjects who could not
follow the usual practice, we might have been introducing
a selection bias; however, given that our population was
not excluded neither because of their comorbidities nor
because of their ability to answer the questionnaires, this
selection bias is probably minimum. Moreover, we were
also not able to draw any casual links between the sur-
gery, type of pre-fracture or post-fracture care received,
and their recovery in terms of LOS, complications, and
functionality at discharge. Finally, the low mortality rates
might be related with the criteria of participating centres’
selection, which had to have some kind of “medical care”
for these patients. On the contrary, our study has several
strengths, as are the prospective data collection, the wide
representativeness of the participating centres, selected by
size and geographical region, and the consecutive sam-
pling of cases. All these elements contribute to the exter-
nal validity of the data, minimising the likelihood of bias.
Conclusions
Overall, the care of hip fractures admitted to Spanish hospitals
seems in line with other registries published in recent years.
The delays detected in the initiation of the surgery and reha-
bilitation did not affect the total length of stay or in the in-
patient mortality, which were below what has been reported in
other countries. As new models of care are created in order to
give a better response to the patients’ needs during the care of
the hip fracture, it is uncertain which model may work best.
The multidisciplinary approach carried out by most of the
Spanish hospitals seems to follow the latest trend in fracture
patient care although secondary prevention treatment is still
strikingly low.Fig. 2 Kaplan-Meier estimates: cumulative mortality stratified by sex
Fig. 1 Kaplan-Meier estimates: cumulative mortality
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